TRAK vs XRAY · P/E 25, rev $17.7M vs rev $1.78B
ReposiTrak (TRAK) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
ReposiTrak (TRAK) is a software - application company listed on NYSE.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported TRAK revenue for 2026-03-31 was $17.7M. Net income was $5.5M. Revenue was up 49.7% from 2025-12-31 to 2026-03-31. TRAK currently screens at market cap $167.9M and trailing P/E 25.0.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
TRAK currently screens at market cap $167.9M and trailing P/E 25.0. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the TRAK and XRAY stock pages for the full models.
Not investment advice.